- International Medical Press
Professional & Business
- International Medical Press
Meningitis vaccination plan for Hampshire schoolchildren
- International Medical Press
NHS budget cuts leave sexual health services at ‘breaking point’
- International Medical Press
Wales to adopt new regulations for blood donation
- International Medical Press
NICE: GPs urged to create national autism register
- International Medical Press
£1.3bn recruitment plan for mental health
New in Gynaecologic cancers
- UK Medical News
- 1 comment
Lung and stomach cancer are the top cancer killers in England
Even though survival has increased in recent years, the effect of cancer on life expectancy varies across socio-economic groups.
- Global Medical News
- 1 comment
European Medicines Agency recommends approval of 4 cancer drugs
The European Medicines Agency has recommended marketing authorisation for two new oncology therapies, one generic product and one biosimilar.
- Clinical Essentials from US Preventive Services Task Force
- 1 comment
- FULLTEXT
USPSTF issues draft guidance for cervical cancer screening
Most women should receive PAP or HPV test, but not both.
- Clinical Essentials from Lancet
- 1 comment
Recurrent ovarian cancer: maintenance rucaparib prolongs PFS
Phase 3 data from ARIEL3.
- Univadis
- no comment
ESMO 2017: Study confirms chemoradiation is the best treatment for locally advanced cervical cancer compared with neoadjuvant chemotherapy followed by surgery
The incidence of locally advanced cervical cancer is decreasing in Europe due to screening and vaccine campaign, but it’s still common in developing countries and even in the United States due to the lack of medical coverage.
- Clinical Essentials from FDA
- 1 comment
- FULLTEXT
FDA approves bevacizumab biosimilar for cancer
Mvasi is the first biosimilar to be approved for cancer indications in the United States.
- Clinical Essentials from Gynecol Oncol
- 1 comment
Rucaparib shows promise in relapsed high-grade ovarian cancer
Integrated data analysis from Study 10 and ARIEL2.
- Global Clinical Summaries from Obstet Gynecol
- 1 comment
HPV herd effect emerging in US, even among unvaccinated women
Data suggest that small declines in HPV rates may be associated with a herd effect.
- Univadis
- 1 comment
ESMO 2017: 3-week dosing schedule for paclitaxel is suitable as first-line treatment for European women with ovarian cancer
After a Japanese study showed increased progression free-survival interval with a dose-dense weekly paclitaxel treatment, ICON8 demonstrate that there is no difference for Caucasian women.
- Univadis
- 1 comment
ESMO 2017: One in four small and early-stage breast cancers can be aggressive and benefit from adjuvant chemotherapy
Clinical risk assessment for recurrence and metastasis is not enough to avoid adjuvant chemotherapy. Genomic assessment can help to identify those at higher risk that benefit from treatments.
- Clinical Essentials from Lancet
- 1 comment
New vaccine protects against 9 types of HPV
Phase 3 trial shows 97% efficacy against high-grade cervical, vulvar, and vaginal disease
- UK Medical News
- 1 comment
BP medications not tied to breast cancer risk
Long term use of ACEi/ARBs may confer some protection.
- UK Medical News
- 1 comment
Statins have no protective effect against endometrial cancer
Findings from a meta-analysis.
- Global Monthly Essentials
- no comment
Primary Care Oncology: Monthly Essentials September 2017
Most lifesaving starting age for mammograms | Reduced CRC mortality risk with flex sigmoidoscopy | Cochrane review of HPV testing vs cervical cytology | Menopause management after breast cancer.